Clinical Trials in Pittsburgh

Showing 9901-9920 of 16,007 trials

Internet Psychotherapy for Bipolar Disorder in Primary Care

NCT02448108

The investigators will conduct a small pilot study to test the feasibility and acceptability of treating bipolar disorder (BP) in primary care with online psychotherapy delivered both with and without telephone, text, and email support from a clinical helper (CH). The ultimate goal of this work is to provide preliminary data needed to design a larger scale effectiveness study of online psychotherapy for treating BP in primary care.

Bipolar Disorder

University of Pittsburgh47 participantsStarted Mar 2017

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers

NCT02706717

The purpose of the study was to evaluate whether the probiotic Visbiome Extra Strength reduces inflammation in HIV-infected men and women when compared to a placebo (inactive medication like a dummy pill). The study evaluated whether taking Visbiome Extra Strength by mouth for 24 weeks was safe and well-tolerated for HIV-infected persons on antiretroviral therapy (ART). Probiotics are germs such as yeast or bacteria that are found in food and supplements that are used to improve the health of the digestive system. Many people refer to probiotics as "helpful bacteria." These bacteria live in the body and help the body work normally. In some medical conditions, including HIV infection, helpful bacteria are replaced with bacteria that can change the normal intestinal function and increase inflammation. The investigators tested whether giving a probiotic restored normal intestinal function and decreased inflammation.

HIV-1 Infection

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections93 participantsStarted Apr 2016

Birmingham, Alabama, United States • Los Angeles, California, United States • San Diego, California, United States +22 more locations

Internet Psychotherapy for Bipolar Disorder in Primary Care

Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers

Find Trials by Condition in Pittsburgh

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea

Genomics Used to Improve DEpression Decisions

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Answer ALS: Individualized Initiative for ALS Discovery

A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord Injury

A Study of Gene Polymorphisms Associated With Specific Presentations of Sexual Addiction

Study to Evaluate DNL201 in Subjects With Parkinson's Disease

Radiesse® Safety Study For the Treatment of Hands

A Non-Interventional Interview Study of Phenylketonuria (PKU) Adults

Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia